• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: TERUMO BCT SPECTRA OPTIA; SPECTRA OPTIA COLLECT SET

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

TERUMO BCT SPECTRA OPTIA; SPECTRA OPTIA COLLECT SET Back to Search Results
Catalog Number 12120
Device Problems Clumping in Device or Device Ingredient (1095); Use of Device Problem (1670); Obstruction of Flow (2423); Adverse Event Without Identified Device or Use Problem (2993); Pressure Problem (3012)
Patient Problem No Known Impact Or Consequence To Patient (2692)
Event Date 07/26/2018
Event Type  malfunction  
Manufacturer Narrative
Investigation: per the customer, they performed a collection on (b)(6) 2018 and then twice on (b)(6) 2018 with no further collections performed for this patient.A review of the device history record (dhr) for this unit showed no irregularities during manufacturing that were relevant to this issue.Investigation is in process, a follow-up report will be provided.
 
Event Description
The customer reported that during a stem cell collection procedure, the operator noticed clumping at the connector shortly before the procedure was unexpectedly terminated at approximately 172 minutes.The ac ratio was adjusted from 13.5:1 to 8:1 and the chamber volume was collected.The system then returned to re-establishing interface, a return pressure alarm occured and the centrifuge stopped.They were unable to resolve the alarm and they noticed that the patient's femoral lines was clotted.Rinseback was not performed.Per the laboratory at the customer site, the product was clotted and therefore they were unable to process and use as part of the transplant.The customer set up another spectra optia machine the same day and was able to collected for another 155 mins using an ac ratio of 8:1.It was reported that they saw some further clotting, therefore, the patient was given a heparin bolus of 2500 iu and the procedure was finished with no further issues.Due to eu personal data protection laws, the patient information and outcome are not available from the customer.The stem cell collection set is not available for return because it was discarded by the customer.
 
Manufacturer Narrative
This report is being filed to provide additional information.Investigation: the run data file was analyzed for this event.Review of the dlog and images for the procedure, did show signs of clumping in the connector starting at 48 minutes into the run and continuing to worsen throughout the procedure.The inlet:ac ratio was set at 13.5 for this procedure and was not changed until 154 minutes into the run when it was decreased to 10.At 158 minutes into the run, the ¿decrease inlet:ac ratio¿ button was pressed which decreased the inlet:ac ratio to 8:1 while the system processed 100ml of inlet volume.Six minutes later, there were two ¿return pressure was too high¿ alarms and the procedure was ended by the operator.Rinseback was not performed.Root cause: root cause remains undetermined at this time.In general, the likelihood for platelet clumping to occur during a run is difficult to predict since it is not dependent on a specific platelet count and varies by patient.The default inlet:ac ratio for mnc procedures is 12.This value maybe increased to accommodate the needs of the procedure; however, those needs should be balanced with the increased risk of platelet clumping and separation issues as increasing the ratio decreases how well the extracorporeal circuit is anticoagulated.Therefore, every procedure should be observed for clumping in the connector, particularly at the interface before the collect port and the collect port.If a clump is observed in these locations, it is best to eliminate it and stop the clotting cascade as quickly as possible by reducing the inlet:ac ratio to 8 immediately before it continues to worsen as it is more difficult to address.
 
Event Description
Patient gender and weight were obtained from the run data files (rdf).
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
SPECTRA OPTIA
Type of Device
SPECTRA OPTIA COLLECT SET
Manufacturer (Section D)
TERUMO BCT
lakewood CO 80215
Manufacturer Contact
steve kern
10810 w. collins ave
lakewood, CO 80215
3032392246
MDR Report Key7802375
MDR Text Key118253824
Report Number1722028-2018-00223
Device Sequence Number1
Product Code GKT
UDI-Device Identifier05020583121201
UDI-Public05020583121201
Combination Product (y/n)N
Reporter Country CodeGB
PMA/PMN Number
BK150251
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type foreign,health professional
Reporter Occupation Other Health Care Professional
Type of Report Initial,Followup
Report Date 08/21/2018
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received08/21/2018
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date12/01/2019
Device Catalogue Number12120
Device Lot Number1712153330
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Was the Report Sent to FDA? Yes
Date Manufacturer Received09/20/2018
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured12/19/2017
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Other;
Patient Weight112
-
-